Health ❯ Healthcare ❯ Clinical Trials

Research Studies

Patient Outcomes Drug Efficacy Phase 3 Trials Alzheimer's Research Eli Lilly Parkwood Hospital UFRJ Research NIH Studies Vision Improvement Efficacy Testing

GLP-1 Drugs Linked to Better Breast Cancer Survival in Large EHR Study

The analysis of health records cannot show the drugs caused the gains.

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

Blood Test Detects Alzheimer’s Risk Years Before PET Scans

Butantan Strikes Deal to Make CAR-T in Brazil as New Case Points to Wider Uses

Menopause-Style HRT Patches Match Injections for Prostate Cancer Control

Keio Spinout Plans iPS Cell Trial for Spinal Cord Injury as Early as 2027

Southampton Launches Violet Trial of Diagnostic Tampon for Early Ovarian Cancer Detection

Oral Semaglutide Cuts Serious Heart-Failure Events 22% in Type 2 Diabetes With Heart Failure

Four-Marker Blood Test Shows About 92% Accuracy for Early Pancreatic Cancer in Retrospective Study

Brazil Advances Injectable HIV PrEP Rollout, Explores Local Production After Fiocruz–Gilead Memorandum

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

Brazil Authorizes Leqembi for Early-Stage Alzheimer’s Treatment

Finger-Prick Dried Blood Test Flags Alzheimer’s Biomarkers in European Study

Monthly Tezepelumab Shot Lets Over Half With Severe Asthma Stop Daily Steroids, International Trial Finds

Shingles Vaccine, Viagra and Riluzole Topped Exeter-Led List for Potential Alzheimer’s Repurposing

Swansea Mother Raises Funds to Seek Experimental Options After Son, 4, Is Diagnosed With Sanfilippo

Personalized Vitamin D Strategy Halves Risk of Repeat Heart Attack in Randomized Trial

Health Canada Conditionally Authorizes First Alzheimer’s Drug to Slow Early Decline

AI-Enabled Blood Test Flags HPV-Linked Head and Neck Cancers Up to 10 Years Early